SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Undervalued Biotech Stocks
An SI Board Since March 2017
Posts SubjectMarks Bans Symbol
5 5 0 AUPH, TBRA
Emcee:  markdevera92 Type:  Moderated
Hi this is mark and I am here to post my stock picks that I think are more likely to double or become a multi bagger. I have some bad losses as well as some big wins.

The big wins are

RLYP $16 to $32
TBRA $5 to $38
AUPH $2.25 to $8

I am here again to find undervalued biotech stocks that will double or quadruple from here.
I found that multi bagger stocks have 3 criteria and they are

1. It has to be small cap stocks preferably under $500 million or less but can go up to $1 billion
2. The company's drug has to address a big market such as cancer and other diseases that has a big large market.
3. The drug has to prove after phase 2 that it is both effective and safe.

I think the next big winners will be VSAR, GBT, DEPO and FOLD.
I will be posting more picks as soon as I find a new gem.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):